RIL
ELDN icon

Rothschild Investment LLC’s Eledon Pharmaceuticals ELDN Stock Holding History

Rothschild Investment LLC’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65K Buy
419
+373
+811% +$1.36K ﹤0.01% 2840
2026
Q1 		$142 Buy
46
+22
+92% +$52 ﹤0.01% 3357
2025
Q4 		$36 Buy
+24
New +$57 ﹤0.01% 3293

Other funds holding ELDN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PNFS
PW Nova Financial Services Newtown, Pennsylvania $466M AUM

Rothschild Investment LLC's ELDN Position: Q2 2026 in Review

Rothschild Investment LLC increased its Eledon Pharmaceuticals (ELDN) stake by 811% in Q2 2026, buying an estimated $1.36K and bringing the position to 419 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

Rothschild Investment LLC first reported a position in ELDN in Q4 2025 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Rothschild Investment LLC held 419 shares of Eledon Pharmaceuticals worth $1.65K as of Q2 2026.
  • Rothschild Investment LLC bought 373 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2840 holding.
  • Rothschild Investment LLC first reported a position in Eledon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.